Cullinan Management share price logo

Cullinan Management

NASDAQ: CGEM

Small Cap

$14.33

-0.59

(-3.95%)

Live

as on

Cullinan Management Stock Performance

as on October 24, 2026 at 6:27 am IST

  • Day's Low

    Day's High

    $13.86
    $14.70
    downward going graph

    3.28%

    Downside

    2.58%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.73
    $23.19
    downward going graph

    53.02%

    Downside

    61.83%

    Upside

    downward going graph

Cullinan Management share price movements today

Previous Close
$14.92
Open
$14.70
Volume
397.4K
Market Cap
$924.9M
Day's Low - High
$13.86 - $14.70
52 Week Low - High
$6.73 - $23.19

Cullinan Management Historical Returns

1 Month Return
-11.56 %
3 Month Return
-13.66 %
1 Year Return
+ 93.01 %
3 Year Return
+ 77.41 %
5 Year Return
-32.82 %

Cullinan Management Stock Fundamentals & Key Indicators

Check Cullinan Management market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$924.9M

EPS (TTM)

-3.37

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.42

Industry PE ratio

-7.12

PEG Ratio

-1.41

EBITDA

-208.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-52.89%

Cullinan Management vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cullinan Management with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$924.9M-32.82%-4.420.00%0.00%
Neutral$98.1B-37.95%-30.80-12.57%0.00%
StrongBuy$44.0BNA27.4787.82%0.00%
StrongBuy$132.9B191.61%30.2886.04%0.00%
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for Cullinan Management Stock including INR - Dollar returns

The Cullinan Management stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Cullinan Management investment value today

Current value as on today

₹2,00,505

Returns

₹1,00,505

(+100.51%)

Returns from Cullinan Management Stock

₹85,382 (+85.38%)

Dollar Impact

₹15,123 (+15.12%)

Analyst Recommendation on Cullinan Management Stock

Based on 7 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for Cullinan Management. Average target price of $33.45

Cullinan Management Share Price Target

Get share price movements and forecasts by analysts on Cullinan Management.

What analysts predicted

57.16%UPSIDE

Target Price

$33.45

Current Price

$14.33

Analyzed by

7 Analysts

High

$42

Target

$33.45

Low

$28

Cullinan Management target price $33.45, a slight upside of 57.16% compared to current price of $14.33. According to 7 analysts rating.

Indian Investors' Interest in Cullinan Management Stock

Search interest for Cullinan Management Stock has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:26% versus previous 30 day period

Cullinan Management Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-
-
-
-
Operating Income
-42
-50
-48
-55
-54
-75
-55
-55
-53
-57
EBITDA
-37
-41
-40
-47
-48
-69
-50
-50
-53
-53
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-37
-42
-40
-47
-48
-70
-50
-50
-49
-53
Income Tax Expense
-
-
-
0
-
-
-
-
-
-
Net Income
-37
-42
-40
-47
-48
-70
-50
-50
-49
-53
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cullinan Management Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
18
-
-
-
-
Gross Profit
0
0
0
18
-
0
0
-
Operating Income
-14
-22
-60
-67
144
-191
-196
-241
EBITDA
-14
-22
-60
-67
-132
-190
-167
-219
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-14
-21
-59
-67
151
-169
-167
-219
Income Tax Expense
-
-
-
-
42
-14
0
-
Net Income
-14
-20
-51
-65
111
-153
-167
-219
Net Profit Margin
0.00%
0.00%
0.00%
100.00%
0.00%
0.00%
0.00%
0.00%

Cullinan Management Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-37
-42
-40
-47
-48
-70
-50
-50
-49
-53
Operating Cash Flow
-38
-36
-34
-36
-43
-57
-36
-38
-46
-38
Investing Cash Flow
12
-185
19
15
36
53
67
22
32
40
Financing Cash Flow
1
262
1
1
-
0
-
0
0
1
Change in Cash
-24
40
-12
-19
-6
-3
30
-15
-13
3

Cullinan Management Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-14
-20
-51
-67
109
-153
-167
-219
Operating Cash Flow
-13
-20
-29
-43
-126
-134
-145
-175
Investing Cash Flow
0
-35
-5
-333
248
35
-136
179
Financing Cash Flow
0
85
140
268
-25
40
266
1
Change in Cash
-13
29
104
-108
96
-57
-15
5

Global Institutional Holdings in Cullinan Management

Check out the Institutions with significant holdings in Cullinan Management.

Funds
Holdings
Dimensional
0.36%
Louis Moore Bacon
0.30%
Avantis
0.24%
SCHWAB CAPITAL TRUST
0.24%
VANGUARD WORLD FUND
0.14%

Cullinan Management News & Key Events

  • img

    Today's Timeline - 24 September

    Thu, 04:45 PM

    -

    Cullinan Therapeutics outlines Q4 2026 milestones across immunology and oncology pipeline, including key data releases for CLN-978 and CLN-049.

    Thu, 07:13 PM

    -

    Cullinan highlights Q4 milestones, expects data updates for T cell engagers in November and December, maintaining a Buy rating.

    Thu, 09:00 PM

    -

    Cullinan shares fall 7% after delaying CLN-978 data release to December, previously expected in Q3.

  • img

    Today's Timeline - 24 September

    Thu, 10:45 PM

    -

    TD Cowen sees buying opportunity in Cullinan shares after recent weakness, citing a catalyst-rich roadmap for Q4.

Insights on Cullinan Management

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CGEM stock has moved up by 15.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 578.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 157.7% return, outperforming this stock by 80.3%

About Cullinan Management

Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States. It engages in the development of CLN-978, a CD19xCD3 bispecific T cell engager for autoimmune diseases in Phase 1 clinical trials; Velinotamig, a BCMAxCD3 bispecific T cell in Phase 1 clinical trials in patients with autoimmune diseases; and CLN-049, a FLT3xCD3 bispecific T cell engager, which is in Phase 1 clinical trials in patients with relapsed and refractory acute myeloid leukemia or myelodysplastic syndrome. The company is also developing Zipalertinib, an orally available small-molecule, irreversible epidermal growth factor receptor inhibitor in Phase 2b portion of the REZILIENT1 clinical trial in patients with EGFR ex20ins non-small cell lung cancer. It has a license agreement with Chongqing Genrix Biopharmaceutical Co., Ltd to develop and commercialize velinotamig; a co-development agreement with Taiho Pharmaceutical Co., Ltd to develop zipalertinib; and a collaboration agreement with Adimab, LLC to discover and/or optimize antibodies. The company was formerly known as Cullinan Oncology, Inc. and changed its name to Cullinan Therapeutics, Inc. in April 2024. Cullinan Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
OrganisationCullinan Management
HeadquartersOne Main Street, Cambridge, MA, 02142, US
IndustryBiotechnology
CEONadim Ahmed

Key Management of Cullinan Management

Name

Title

Ms. Rose Weldon

Senior Vice President of Corporate Affairs

Mr. Nadim Ahmed M.S.

President, CEO & Director

Dr. Jeffrey Jones M.B.A., M.D., M.P.H.

Chief Medical Officer

Nicholas Smith

Head of Investor Relations

Ms. Jacquelyn L. Sumer J.D.

Chief Legal Officer, Chief Compliance Officer & Corporate Secretary

Mr. Steve Andre

Chief Human Resources Officer

Dr. Corinne Savill Ph.D.

Chief Business Officer

Ms. Mary Kay Fenton CPA

Chief Financial Officer

Dr. Patrick A. Baeuerle Ph.D.

Co-Founder, Chief Scientific Advisor & Chairman of Scientific Advisory Board

Dr. Jennifer Michaelson Ph.D.

Chief Scientific Officer

FAQs

What is Cullinan Management share price today?

Cullinan Management share price today is $14.33 as on . Cullinan Management share today touched a day high of $14.70 and a low of $13.86.

What is the 52 week high and 52 week low for Cullinan Management share?

Cullinan Management share touched a 52 week high of $23.19 on and a 52 week low of $6.73 on . Cullinan Management stock price today i.e. is trending at $14.33,which is 38.21% down from its 52 week high and 112.87% up from its 52 week low.

What is Cullinan Management's market capitalisation today?

Cullinan Management market capitalisation is $0.00T as on .

How to invest in Cullinan Management Stock (CGEM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cullinan Management on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Cullinan Management Stock (CGEM) from India?

Indian investors can start investing in Cullinan Management (CGEM) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Cullinan Management stock (as per the Rupee-Dollar exchange rate as on ). Based on Cullinan Management share’s latest price of $14.33 as on October 24, 2026 at 12:57 am IST, you will get 0.6978 shares of Cullinan Management. Learn more about fractional shares .

What are the returns that Cullinan Management has given to Indian investors in the last 5 years?

Cullinan Management stock has given -32.82% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?